Table 1.
Demographic information for both study groups and clinical characteristics of the schizophrenia group
| Schizophrenia Group (n = 19) Mean (SD) |
Control Group (n = 18) Mean (SD) |
statistics | p value | |
|---|---|---|---|---|
| Gender (male/female) | 12 / 6 | 11/8 | Chi2 = 0.3 | n.s. |
| Age | 37.4 (8.4) | 37.6 (10.9) | t = 0.1 | n.s. |
| Educationa | 2/5/6/6 | 1/2/7/8 | Fisher’s exact test | n.s. |
| Illness duration (years) | 12.2 (6.3) | – | ||
| In−/Outpatients | 9 / 10 | – | ||
| CPZ equivalent dose | 716 mg (337) | – | ||
| PANSS total score | 77.7 (18.5) | – | ||
| PANSS positive subscore | 17.6 (6.7) | – | ||
| PANSS negative subscore | 20.3 (6.8) | – | ||
| PANSS general subscore | 39.8 (9.1) | – | ||
| PSP | 59.5 (16.1) | – |
a1 = elementary school; 2 = high school; 3 = vocational school; 4 = college/university
(CPZ = chlorpromazine equivalent dose; PANSS = Positive and Negative Symptoms Scale; PSP = Personal and Social Performance Scale)